Tumor-spezifische T-Zellen und T-Zellepitope  bei kutanen LymphomenTumenjargal SharavFür meine Eltern11234252.162.272.2.1892.2.2102.2.3112.2.42.2.52.3132.3.1142.3.215162.3.31718319204214.14.1.14.1.2224.1.323604#3474.1.4244.2254.2.14.2.24.2.3264.34.3.145#2548#242741#254.3.24.4284.4.14.4.24.4.34.4.44.54.5.1304.5.24.5.3314.5.44.5.54.5.6324.5.7334.5.8345355.15.1.136109#4837#2337#23127#4540#2448#245.1.23738594#2795.1.339559#265516#204405.1.441604#2434243445.1.54546283#2295.1.647600#269484950600#357515.25232#2453318#374132#44141#4916#1754461#41655565.35758596061461#23962256#22663480#216645.465546#354529#2066667859#6055.56970605#49671242#28072595#3375.673602#20174569#67575453#25476677787980818283848587888990919279394 8. Literaturverzeichnis95 9. Anhang11610. PublikationenslisteSelbständigkeitserklärungDanksagungdeInhaltsverzeichnisHilfe 8. Literaturverzeichnis Abelev, G. I.; Perova, S. D.; Khramkova, N. I.; Postnikova, Z. A. and Irlin, I. S. (1963): Production of embryonal alpha-globulin by transplantable mouse hepatomas, Transplantation 1, pp.174-80. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14010646 Agarwala, K. L.; Kokame, K.; Kato, H. and Miyata, T. (2000): Phosphorylation of RTP, an ER stress-responsive cytoplasmic protein, Biochem Biophys Res Commun 272 [3], pp.641-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10860807 Amrani, A.; Verdaguer, J.; Serra, P.; Tafuro, S.; Tan, R. and Santamaria, P. (2000): Progression of autoimmune diabetes driven by avidity maturation of a T-cell population, Nature 406 [6797], pp.739-42. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10963600 Asadullah, K.; Docke, W. D.; Haeussler, A.; Sterry, W. and Volk, H. D. (1996): Progression of mycosis fungoides is associated with increasing cutaneous expression of interleukin-10 mRNA, J Invest Dermatol 107 [6], pp.833-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8941670 Bachmair, A. and Varshavsky, A. (1989): The degradation signal in a short-lived protein, Cell 56 [6], pp.1019-32. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2538246 Bagot, M.; Echchakir, H.; Mami-Chouaib, F.; Delfau-Larue, M. H.; Charue, D.; Bernheim, A.; Chouaib, S.; Boumsell, L. and Bensussan, A. (1998): Isolation of tumor-specific cytotoxic CD4+ and CD4+CD8dim+ T-cell clones infiltrating a cutaneous T-cell lymphoma, Blood 91 [11], pp.4331-41. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9596682 Bagot, M.; Nikolova, M.; Schirm-Chabanette, F.; Wechsler, J.; Boumsell, L. and Bensussan, A. (2001): Crosstalk between tumor T lymphocytes and reactive T lymphocytes in cutaneous T cell lymphomas, Ann N Y Acad Sci 941, pp.31-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11594580 Berger, C. L.; Longley, J.; Hanlon, D.; Girardi, M. and Edelson, R. (2001): The clonotypic T cell receptor is a source of tumor-associated antigens in cutaneous T cell lymphoma, Ann N Y Acad Sci 941, pp.106-22. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11594564 Berger, C. L.; Wang, N.; Christensen, I.; Longley, J.; Heald, P. and Edelson, R. L. (1996): The immune response to class I-associated tumor-specific cutaneous T-cell lymphoma antigens, J Invest Dermatol 107 [3], pp.392-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8751976 Bernengo, M. G.; Novelli, M.; Quaglino, P.; Lisa, F.; De Matteis, A.; Savoia, P.; Cappello, N. and Fierro, M. T. (2001): The relevance of the CD4+ CD26- subset in the identification of circulating Sezary cells, Br J Dermatol 144 [1], pp.125-35. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11167693 Birmingham, K. (2002): Judah Folkman, Nat Med 8 [10], p.1052. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12357229 Bjorkman, P. J.; Saper, M. A.; Samraoui, B.; Bennett, W. S.; Strominger, J. L. and Wiley, D. C. (1987): Structure of the human class I histocompatibility antigen, HLA-A2, Nature 329 [6139], pp.506-12. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3309677 Blake, J.; Johnston, J. V.; Hellstrom, K. E.; Marquardt, H. and Chen, L. (1996): Use of combinatorial peptide libraries to construct functional mimics of tumor epitopes recognized by MHC class I-restricted cytolytic T lymphocytes, J Exp Med 184 [1], pp.121-30. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8691125 Blattman, J. N.; Antia, R.; Sourdive, D. J.; Wang, X.; Kaech, S. M.; Murali-Krishna, K.; Altman, J. D. and Ahmed, R. (2002): Estimating the precursor frequency of naive antigen-specific CD8 T cells, J Exp Med 195 [5], pp.657-64. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11877489 Blom, B.; Verschuren, M. C.; Heemskerk, M. H.; Bakker, A. Q.; van Gastel-Mol, E. J.; Wolvers-Tettero, I. L.; van Dongen, J. J. and Spits, H. (1999): TCR gene rearrangements and expression of the pre-T cell receptor complex during human T-cell differentiation, Blood 93 [9], pp.3033-43. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10216100 Bobryshev, Y. V.; Lord, R. S.; Watanabe, T. and Ikezawa, T. (1998): The cell adhesion molecule E-cadherin is widely expressed in human atherosclerotic lesions, Cardiovasc Res 40 [1], pp.191-205. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9876332 Bowman, M. R.; Crimmins, M. A.; Yetz-Aldape, J.; Kriz, R.; Kelleher, K. and Herrmann, S. (1994): The cloning of CD70 and its identification as the ligand for CD27, J Immunol 152 [4], pp.1756-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8120384 Braciale, T. J. and Braciale, V. L. (1991): Antigen presentation: structural themes and functional variations, Immunol Today 12 [4], pp.124-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1711855 Brinckerhoff, L. H.; Kalashnikov, V. V.; Thompson, L. W.; Yamshchikov, G. V.; Pierce, R. A.; Galavotti, H. S.; Engelhard, V. H. and Slingluff, C. L., Jr. (1999): Terminal modifications inhibit proteolytic degradation of an immunogenic MART-1(27-35) peptide: implications for peptide vaccines, Int J Cancer 83 [3], pp.326-34. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10495424 Brock, R.; Wiesmuller, K. H.; Jung, G. and Walden, P. (1996): Molecular basis for the recognition of two structurally different major histocompatibility complex/peptide complexes by a single T-cell receptor, Proc Natl Acad Sci U S A 93 [23], pp.13108-13. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8917552 Brown, J. H.; Jardetzky, T. S.; Gorga, J. C.; Stern, L. J.; Urban, R. G.; Strominger, J. L. and Wiley, D. C. (1993): Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1, Nature 364 [6432], pp.33-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8316295 Bullock, T. N.; Patterson, A. E.; Franlin, L. L.; Notidis, E. and Eisenlohr, L. C. (1997): Initiation codon scanthrough versus termination codon readthrough demonstrates strong potential for major histocompatibility complex class I-restricted cryptic epitope expression, J Exp Med 186 [7], pp.1051-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9314554 Busch, D. H. and Pamer, E. G. (1999): T cell affinity maturation by selective expansion during infection, J Exp Med 189 [4], pp.701-10. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9989985 Butterfield, L. H.; Koh, A.; Meng, W.; Vollmer, C. M.; Ribas, A.; Dissette, V.; Lee, E.; Glaspy, J. A.; McBride, W. H. and Economou, J. S. (1999): Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein, Cancer Res 59 [13], pp.3134-42. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10397256 Cangul, H.; Salnikow, K.; Yee, H.; Zagzag, D.; Commes, T. and Costa, M. (2002): Enhanced expression of a novel protein in human cancer cells: a potential aid to cancer diagnosis, Cell Biol Toxicol 18 [2], pp.87-96. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12046693 Cardinaud, S.; Moris, A.; Fevrier, M.; Rohrlich, P. S.; Weiss, L.; Langlade-Demoyen, P.; Lemonnier, F. A.; Schwartz, O. and Habel, A. (2004): Identification of Cryptic MHC I-restricted Epitopes Encoded by HIV-1 Alternative Reading Frames, J Exp Med 199 [8], pp.1053-1063. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15078897 Carreno, B. M. and Collins, M. (2002): The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses, Annu Rev Immunol 20, pp.29-53. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11861596 Castelli, C.; Storkus, W. J.; Maeurer, M. J.; Martin, D. M.; Huang, E. C.; Pramanik, B. N.; Nagabhushan, T. L.; Parmiani, G. and Lotze, M. T. (1995): Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes, J Exp Med 181 [1], pp.363-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7807017 Chen, J. L.; Dunbar, P. R.; Gileadi, U.; Jager, E.; Gnjatic, S.; Nagata, Y.; Stockert, E.; Panicali, D. L.; Chen, Y. T.; Knuth, A.; Old, L. J. and Cerundolo, V. (2000): Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL, J Immunol 165 [2], pp.948-55. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10878370 Clay, T. M.; Custer, M. C.; McKee, M. D.; Parkhurst, M.; Robbins, P. F.; Kerstann, K.; Wunderlich, J.; Rosenberg, S. A. and Nishimura, M. I. (1999): Changes in the fine specificity of gp100(209-217)-reactive T cells in patients following vaccination with a peptide modified at an HLA-A2.1 anchor residue, J Immunol 162 [3], pp.1749-55. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9973438 Coulie, P. G.; Lehmann, F.; Lethe, B.; Herman, J.; Lurquin, C.; Andrawiss, M. and Boon, T. (1995): A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma, Proc Natl Acad Sci U S A 92 [17], pp.7976-80. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7644523 Crawford, F.; Kozono, H.; White, J.; Marrack, P. and Kappler, J. (1998): Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes, Immunity 8 [6], pp.675-82. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9655481 Dal Porto, J.; Johansen, T. E.; Catipovic, B.; Parfiit, D. J.; Tuveson, D.; Gether, U.; Kozlowski, S.; Fearon, D. T. and Schneck, J. P. (1993): A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations, Proc Natl Acad Sci U S A 90 [14], pp.6671-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8341685 Denzin, L. K. and Cresswell, P. (1995): HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading, Cell 82 [1], pp.155-65. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7606781 Derby, M. A.; Wang, J.; Margulies, D. H. and Berzofsky, J. A. (2001): Two intermediate-avidity cytotoxic T lymphocyte clones with a disparity between functional avidity and MHC tetramer staining, Int Immunol 13 [6], pp.817-24. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11369710 Dereure, O.; Portales, P.; Clot, J. and Guilhou, J. J. (2000): Decreased expression of Fas (APO-1/CD95) on peripheral blood CD4+ T lymphocytes in cutaneous T-cell lymphomas, Br J Dermatol 143 [6], pp.1205-10. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11122022 Ding, Y. H.; Smith, K. J.; Garboczi, D. N.; Utz, U.; Biddison, W. E. and Wiley, D. C. (1998): Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids, Immunity 8 [4], pp.403-11. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9586631 Dutoit, V.; Rubio-Godoy, V.; Dietrich, P. Y.; Quiqueres, A. L.; Schnuriger, V.; Rimoldi, D.; Lienard, D.; Speiser, D.; Guillaume, P.; Batard, P.; Cerottini, J. C.; Romero, P. and Valmori, D. (2001): Heterogeneous T-cell response to MAGE-A10(254-262): high avidity-specific cytolytic T lymphocytes show superior antitumor activity, Cancer Res 61 [15], pp.5850-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11479225 Dutoit, V.; Rubio-Godoy, V.; Doucey, M. A.; Batard, P.; Lienard, D.; Rimoldi, D.; Speiser, D.; Guillaume, P.; Cerottini, J. C.; Romero, P. and Valmori, D. (2002): Functional avidity of tumor antigen-specific CTL recognition directly correlates with the stability of MHC/peptide multimer binding to TCR, J Immunol 168 [3], pp.1167-71. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11801651 Dutton, R. W. (1996): The regulation of the development of CD8 effector T cells, J Immunol 157 [10], pp.4287-92. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8906801 Echchakir, H.; Mami-Chouaib, F.; Vergnon, I.; Baurain, J. F.; Karanikas, V.; Chouaib, S. and Coulie, P. G. (2001): A point mutation in the alpha-actinin-4 gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human lung carcinoma, Cancer Res 61 [10], pp.4078-83. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11358829 Edelman, J. and Meyerson, H. J. (2000): Diminished CD3 expression is useful for detecting and enumerating Sezary cells, Am J Clin Pathol 114 [3], pp.467-77. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10989648 Eichmuller, S. (2002): Towards defining specific antigens for cutaneous lymphomas, Onkologie 25 [5], pp.448-54. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12415200 Eichmuller, S.; Usener, D.; Thiel, D. and Schadendorf, D. (2003): Tumor-specific antigens in cutaneous T-cell lymphoma: expression and sero-reactivity, Int J Cancer 104 [4], pp.482-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12584747 Eisen, H. N.; Sykulev, Y. and Tsomides, T. J. (1996): Antigen-specific T-cell receptors and their reactions with complexes formed by peptides with major histocompatibility complex proteins, Adv Protein Chem 49, pp.1-56. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8908296 Esser, P.; Grisanti, S. and Bartz-Schmidt, K. (2001): TGF-beta in uveal melanoma, Microsc Res Tech 52 [4], pp.396-400. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11170298 Evavold, B. D.; Sloan-Lancaster, J.; Wilson, K. J.; Rothbard, J. B. and Allen, P. M. (1995): Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands, Immunity 2 [6], pp.655-63. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7540944 Fahmy, T. M.; Bieler, J. G.; Edidin, M. and Schneck, J. P. (2001): Increased TCR avidity after T cell activation: a mechanism for sensing low-density antigen, Immunity 14 [2], pp.135-43. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11239446 Falk, K.; Rotzschke, O.; Stevanovic, S.; Jung, G. and Rammensee, H. G. (1994): Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules, Immunogenetics 39 [4], pp.230-42. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8119729 Fischer, J. R.; Schindel, M.; Stein, N.; Lahm, H.; Gallati, H.; Krammer, P. H. and Drings, P. (1995): Selective suppression of cytokine secretion in patients with small-cell lung cancer, Ann Oncol 6 [9], pp.921-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8624296 Fischer, T. C.; Gellrich, S.; Muche, J. M.; Tumenjargal, S.; Audring, H.; Neitzel, H.; Walden, P.; Sterry, W. and Tönnies, H (2004): Genomic aberrations and survival in cutaneous T cell lymphomas, J Inv Dermatol 122 [3], pp.579-586. Fisk, B.; Savary, C.; Hudson, J. M.; O'Brian, C. A.; Murray, J. L.; Wharton, J. T. and Ioannides, C. G. (1995): Changes in an HER-2 peptide upregulating HLA-A2 expression affect both conformational epitopes and CTL recognition: implications for optimization of antigen presentation and tumor-specific CTL induction, J Immunother Emphasis Tumor Immunol 18 [4], pp.197-209. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8680648 Flad, T.; Spengler, B.; Kalbacher, H.; Brossart, P.; Baier, D.; Kaufmann, R.; Bold, P.; Metzger, S.; Bluggel, M.; Meyer, H. E.; Kurz, B. and Muller, C. A. (1998): Direct identification of major histocompatibility complex class I-bound tumor-associated peptide antigens of a renal carcinoma cell line by a novel mass spectrometric method, Cancer Res 58 [24], pp.5803-11. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9865739 Fleckenstein, B.; Kalbacher, H.; Muller, C. P.; Stoll, D.; Halder, T.; Jung, G. and Wiesmuller, K. H. (1996): New ligands binding to the human leukocyte antigen class II molecule DRB1*0101 based on the activity pattern of an undecapeptide library, Eur J Biochem 240 [1], pp.71-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8797837 Fleischer, B. (1994): CD26: a surface protease involved in T-cell activation, Immunol Today 15 [4], pp.180-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7911022 Folkman, J. (2003): Angiogenesis and apoptosis, Semin Cancer Biol 13 [2], pp.159-67. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12654259 Freeman, G. J.; Long, A. J.; Iwai, Y.; Bourque, K.; Chernova, T.; Nishimura, H.; Fitz, L. J.; Malenkovich, N.; Okazaki, T.; Byrne, M. C.; Horton, H. F.; Fouser, L.; Carter, L.; Ling, V.; Bowman, M. R.; Carreno, B. M.; Collins, M.; Wood, C. R. and Honjo, T. (2000): Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation, J Exp Med 192 [7], pp.1027-34. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11015443 Fremont, D. H.; Matsumura, M.; Stura, E. A.; Peterson, P. A. and Wilson, I. A. (1992): Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb, Science 257 [5072], pp.919-27. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1323877 Galy, A.; Verma, S.; Barcena, A. and Spits, H. (1993): Precursors of CD3+CD4+CD8+ cells in the human thymus are defined by expression of CD34. Delineation of early events in human thymic development, J Exp Med 178 [2], pp.391-401. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7688021 Garboczi, D. N.; Ghosh, P.; Utz, U.; Fan, Q. R.; Biddison, W. E. and Wiley, D. C. (1996): Structure of the complex between human T-cell receptor, viral peptide and HLA-A2, Nature 384 [6605], pp.134-41. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8906788 Garcia, K. C.; Degano, M.; Pease, L. R.; Huang, M.; Peterson, P. A.; Teyton, L. and Wilson, I. A. (1998): Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen, Science 279 [5354], pp.1166-72. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9469799 Genestier, L.; Kasibhatla, S.; Brunner, T. and Green, D. R. (1999): Transforming growth factor beta1 inhibits Fas ligand expression and subsequent activation-induced cell death in T cells via downregulation of c-Myc, J Exp Med 189 [2], pp.231-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9892606 Girardi, M.; Lewis, J.; Glusac, E.; Filler, R. B.; Geng, L.; Hayday, A. C. and Tigelaar, R. E. (2002): Resident skin-specific gammadelta T cells provide local, nonredundant regulation of cutaneous inflammation, J Exp Med 195 [7], pp.855-67. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11927630 Guilloux, Y.; Lucas, S.; Brichard, V. G.; Van Pel, A.; Viret, C.; De Plaen, E.; Brasseur, F.; Lethe, B.; Jotereau, F. and Boon, T. (1996): A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene, J Exp Med 183 [3], pp.1173-83. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8642259 Gundlach, B. R.; Wiesmuller, K. H.; Junt, T.; Kienle, S.; Jung, G. and Walden, P. (1996): Specificity and degeneracy of minor histocompatibility antigen-specific MHC-restricted CTL, J Immunol 156 [10], pp.3645-51. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8621898 Guy-Grand, D.; Cerf-Bensussan, N.; Malissen, B.; Malassis-Seris, M.; Briottet, C. and Vassalli, P. (1991): Two gut intraepithelial CD8+ lymphocyte populations with different T cell receptors: a role for the gut epithelium in T cell differentiation, J Exp Med 173 [2], pp.471-81. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1824857 Hasegawa, H.; Nomura, T.; Kohno, M.; Tateishi, N.; Suzuki, Y.; Maeda, N.; Fujisawa, R.; Yoshie, O. and Fujita, S. (2000): Increased chemokine receptor CCR7/EBI1 expression enhances the infiltration of lymphoid organs by adult T-cell leukemia cells, Blood 95 [1], pp.30-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10607681 Hayday, A. C. (2000): [gamma][delta] cells: a right time and a right place for a conserved third way of protection, Annu Rev Immunol 18, pp.975-1026. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10837080 Hemmer, B.; Fleckenstein, B. T.; Vergelli, M.; Jung, G.; McFarland, H.; Martin, R. and Wiesmuller, K. H. (1997): Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone, J Exp Med 185 [9], pp.1651-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9151902 Hemmer, B.; Pinilla, C.; Gran, B.; Vergelli, M.; Ling, N.; Conlon, P.; McFarland, H. F.; Houghten, R. and Martin, R. (2000): Contribution of individual amino acids within MHC molecule or antigenic peptide to TCR ligand potency, J Immunol 164 [2], pp.861-71. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10623833 Herr, I.; Wilhelm, D.; Bohler, T.; Angel, P. and Debatin, K. M. (1997): Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis, Embo J 16 [20], pp.6200-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9321399 Hin, S.; Zabel, C.; Bianco, A.; Jung, G. and Walden, P. (1999): Cutting edge: N-hydroxy peptides: a new class of TCR antagonists, J Immunol 163 [5], pp.2363-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10452967 Hindkjaer, J.; Brandt, C. A. and Kaltoft, K. (1993): Aneuploid malignant T cells from a patient with Sezary syndrome can be visualized by in situ hybridization, Arch Dermatol 129 [9], pp.1141-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8363397 Hintzen, R. Q.; de Jong, R.; Lens, S. M. and van Lier, R. A. (1994): CD27: marker and mediator of T-cell activation?, Immunol Today 15 [7], pp.307-11. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8086099 Horwitz, D. A.; Zheng, S. G. and Gray, J. D. (2003): The role of the combination of IL-2 and TGF-beta or IL-10 in the generation and function of CD4+ CD25+ and CD8+ regulatory T cell subsets, J Leukoc Biol 74 [4], pp.471-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14519757 Howie, D.; Spencer, J.; DeLord, D.; Pitzalis, C.; Wathen, N. C.; Dogan, A.; Akbar, A. and MacDonald, T. T. (1998): Extrathymic T cell differentiation in the human intestine early in life, J Immunol 161 [11], pp.5862-72. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9834065 Hu, H. M.; Dols, A.; Meijer, S. L.; Floyd, K.; Walker, E.; Urba, W. J. and Fox, B. A. (2004): Immunological monitoring of patients with melanoma after peptide vaccination using soluble peptide/HLA-A2 dimer complexes, J Immunother 27 [1], pp.48-59. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14676633 Hunt, D. F.; Michel, H.; Dickinson, T. A.; Shabanowitz, J.; Cox, A. L.; Sakaguchi, K.; Appella, E.; Grey, H. M. and Sette, A. (1992): Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad, Science 256 [5065], pp.1817-20. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1319610 Jensenius, J. C. and Williams, A. F. (1982): The T lymphocyte antigen receptor--paradigm lost, Nature 300 [5893], pp.583-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=6755269 Jochmus, I.; Osen, W.; Altmann, A.; Buck, G.; Hofmann, B.; Schneider, A.; Gissmann, L. and Rammensee, H. G. (1997): Specificity of human cytotoxic T lymphocytes induced by a human papillomavirus type 16 E7-derived peptide, J Gen Virol 78 ( Pt 7), pp.1689-95. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9225046 Jones, D.; Dang, N. H.; Duvic, M.; Washington, L. T. and Huh, Y. O. (2001): Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood, Am J Clin Pathol 115 [6], pp.885-92. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11392886 Ju, S. T.; Panka, D. J.; Cui, H.; Ettinger, R.; el-Khatib, M.; Sherr, D. H.; Stanger, B. Z. and Marshak-Rothstein, A. (1995): Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation, Nature 373 [6513], pp.444-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7530337 Kalergis, A. M.; Boucheron, N.; Doucey, M. A.; Palmieri, E.; Goyarts, E. C.; Vegh, Z.; Luescher, I. F. and Nathenson, S. G. (2001): Efficient T cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex, Nat Immunol 2 [3], pp.229-34. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11224522 Kaltoft, K.; Bisballe, S.; Dyrberg, T.; Boel, E.; Rasmussen, P. B. and Thestrup-Pedersen, K. (1992): Establishment of two continuous T-cell strains from a single plaque of a patient with mycosis fungoides, In Vitro Cell Dev Biol 28A [3 Pt 1], pp.161-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1582990 Kaltoft, K.; Bisballe, S.; Rasmussen, H. F.; Thestrup-Pedersen, K.; Thomsen, K. and Sterry, W. (1987): A continuous T-cell line from a patient with Sezary syndrome, Arch Dermatol Res 279 [5], pp.293-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3498444 Karenko, L.; Hyytinen, E.; Sarna, S. and Ranki, A. (1997): Chromosomal abnormalities in cutaneous T-cell lymphoma and in its premalignant conditions as detected by G-banding and interphase cytogenetic methods, J Invest Dermatol 108 [1], pp.22-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8980281 Kelly, A. P.; Monaco, J. J.; Cho, S. G. and Trowsdale, J. (1991): A new human HLA class II-related locus, DM, Nature 353 [6344], pp.571-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1922365 Kersh, G. J.; Miley, M. J.; Nelson, C. A.; Grakoui, A.; Horvath, S.; Donermeyer, D. L.; Kappler, J.; Allen, P. M. and Fremont, D. H. (2001): Structural and functional consequences of altering a peptide MHC anchor residue, J Immunol 166 [5], pp.3345-54. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11207290 Kokame, K.; Kato, H. and Miyata, T. (1998): Nonradioactive differential display cloning of genes induced by homocysteine in vascular endothelial cells, Methods 16 [4], pp.434-43. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10049651 Kuon, W.; Holzhutter, H. G.; Appel, H.; Grolms, M.; Kollnberger, S.; Traeder, A.; Henklein, P.; Weiss, E.; Thiel, A.; Lauster, R.; Bowness, P.; Radbruch, A.; Kloetzel, P. M. and Sieper, J. (2001): Identification of HLA-B27-restricted peptides from the Chlamydia trachomatis proteome with possible relevance to HLA-B27-associated diseases, J Immunol 167 [8], pp.4738-46. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11591805 Kurdistani, S. K.; Arizti, P.; Reimer, C. L.; Sugrue, M. M.; Aaronson, S. A. and Lee, S. W. (1998): Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage, Cancer Res 58 [19], pp.4439-44. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9766676 La Rosa, C.; Krishnan, R.; Markel, S.; Schneck, J. P.; Houghten, R.; Pinilla, C. and Diamond, D. J. (2001): Enhanced immune activity of cytotoxic T-lymphocyte epitope analogs derived from positional scanning synthetic combinatorial libraries, Blood 97 [6], pp.1776-86. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11238120 Lachat, P.; Shaw, P.; Gebhard, S.; van Belzen, N.; Chaubert, P. and Bosman, F. T. (2002): Expression of NDRG1, a differentiation-related gene, in human tissues, Histochem Cell Biol 118 [5], pp.399-408. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12432451 Laetsch, B.; Haffner, A. C.; Dobbeling, U.; Seifert, B.; Ludwig, E.; Burg, G. and Dummer, R. (2000): CD4 + /CD7- T cell frequency and polymerase chain reaction-based clonality assay correlate with stage in cutaneous T cell lymphomas, J Invest Dermatol 114 [1], pp.107-11. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10620124 Lanzavecchia, A. (1998): Immunology. Licence to kill, Nature 393 [6684], pp.413-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9623994 Le Bouteiller, P. and Lenfant, F. (1996): Antigen-presenting function(s) of the non-classical HLA-E, -F and -G class I molecules: the beginning of a story, Res Immunol 147 [5], pp.301-13. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8876058 Lee, P. P.; Yee, C.; Savage, P. A.; Fong, L.; Brockstedt, D.; Weber, J. S.; Johnson, D.; Swetter, S.; Thompson, J.; Greenberg, P. D.; Roederer, M. and Davis, M. M. (1999): Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients, Nat Med 5 [6], pp.677-85. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10371507 Lin, T. M. and Chang, C. (1997): Cloning and characterization of TDD5, an androgen target gene that is differentially repressed by testosterone and dihydrotestosterone, Proc Natl Acad Sci U S A 94 [10], pp.4988-93. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9144177 Linnemann, T.; Brock, C.; Sparbier, K.; Muche, M.; Mielke, A.; Lukowsky, A.; Sterry, W.; Kaltoft, K.; Wiesmuller, K. H. and Walden, P. (1998): Identification of epitopes for CTCL-specific cytotoxic T lymphocytes, Adv Exp Med Biol 451, pp.231-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10026877 Linnemann, T.; Tumenjargal, S.; Gellrich, S.; Wiesmuller, K.; Kaltoft, K.; Sterry, W. and Walden, P. (2001): Mimotopes for tumor-specific T lymphocytes in human cancer determined with combinatorial peptide libraries, Eur J Immunol 31 [1], pp.156-65. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11169449 Liu, C.; Zhang, L.; Shao, Z. M.; Beatty, P.; Sartippour, M.; Lane, T. F.; Barsky, S. H.; Livingston, E. and Nguyen, M. (2002): Identification of a novel endothelial-derived gene EG-1, Biochem Biophys Res Commun 290 [1], pp.602-12. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11779215 Liu, H.; Hu, B.; Xu, D. and Liew, F. Y. (2003): CD4+CD25+ regulatory T cells cure murine colitis: the role of IL-10, TGF-beta, and CTLA4, J Immunol 171 [10], pp.5012-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14607897 Liyanage, U. K.; Moore, T. T.; Joo, H. G.; Tanaka, Y.; Herrmann, V.; Doherty, G.; Drebin, J. A.; Strasberg, S. M.; Eberlein, T. J.; Goedegebuure, P. S. and Linehan, D. C. (2002): Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma, J Immunol 169 [5], pp.2756-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12193750 Long, E. O.; LaVaute, T.; Pinet, V. and Jaraquemada, D. (1994): Invariant chain prevents the HLA-DR-restricted presentation of a cytosolic peptide, J Immunol 153 [4], pp.1487-94. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8046228 Longthorne, V. L. and Williams, G. T. (1997): Caspase activity is required for commitment to Fas-mediated apoptosis, Embo J 16 [13], pp.3805-12. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9233790 Lucas, M.; Day, C. L.; Wyer, J. R.; Cunliffe, S. L.; Loughry, A.; McMichael, A. J. and Klenerman, P. (2004): Ex vivo phenotype and frequency of influenza virus-specific CD4 memory T cells, J Virol 78 [13], pp.7284-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15194806 MacLennan, I. C.; Gotch, F. M. and Golstein, P. (1980): Limited specific T-cell mediated cytolysis in the absence of extracellular Ca2+, Immunology 39 [1], pp.109-17. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=6769782 Malarkannan, S.; Afkarian, M. and Shastri, N. (1995): A rare cryptic translation product is presented by Kb major histocompatibility complex class I molecule to alloreactive T cells, J Exp Med 182 [6], pp.1739-50. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7500018 Maldonado, A.; Mueller, Y. M.; Thomas, P.; Bojczuk, P.; O'Connors, C. and Katsikis, P. D. (2003): Decreased effector memory CD45RA+ CD62L- CD8+ T cells and increased central memory CD45RA- CD62L+ CD8+ T cells in peripheral blood of rheumatoid arthritis patients, Arthritis Res Ther 5 [2], pp.R91-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12718752 Mason, D. (1998): A very high level of crossreactivity is an essential feature of the T-cell receptor, Immunol Today 19 [9], pp.395-404. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9745202 Masson, D. and Tschopp, J. (1987): A family of serine esterases in lytic granules of cytolytic T lymphocytes, Cell 49 [5], pp.679-85. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3555842 McHugh, R. S.; Whitters, M. J.; Piccirillo, C. A.; Young, D. A.; Shevach, E. M.; Collins, M. and Byrne, M. C. (2002): CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor, Immunity 16 [2], pp.311-23. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11869690 Mielke, V.; Staib, G.; Boehncke, W. H.; Duller, B. and Sterry, W. (1994): Clonal disease in early cutaneous T-cell lymphoma, Dermatol Clin 12 [2], pp.351-60. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8045047 Muche, J. M.; Lukowsky, A.; Asadullah, K.; Gellrich, S. and Sterry, W. (1997): Demonstration of frequent occurrence of clonal T cells in the peripheral blood of patients with primary cutaneous T-cell lymphoma, Blood 90 [4], pp.1636-42. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9269783 Nabholz, M. and Tschopp, J. (1989): CTL-mediated cytolysis: perforin and alternative pathways?, Immunol Lett 20 [3], pp.179-80. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2785499 Nakagawa, T.; Roth, W.; Wong, P.; Nelson, A.; Farr, A.; Deussing, J.; Villadangos, J. A.; Ploegh, H.; Peters, C. and Rudensky, A. Y. (1998): Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus, Science 280 [5362], pp.450-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9545226 Nakamura, K.; Kitani, A. and Strober, W. (2001): Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta, J Exp Med 194 [5], pp.629-44. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11535631 Nasu, K.; Said, J.; Vonderheid, E.; Olerud, J.; Sako, D. and Kadin, M. (1985): Immunopathology of cutaneous T-cell lymphomas, Am J Pathol 119 [3], pp.436-47. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3893149 Nguyen, M.; Corless, C. L.; Kraling, B. M.; Tran, C.; Atha, T.; Bischoff, J. and Barsky, S. H. (1997): Vascular expression of E-selectin is increased in estrogen-receptor-negative breast cancer: a role for tumor-cell-secreted interleukin-1 alpha, Am J Pathol 150 [4], pp.1307-14. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9094987 Ni, X.; Hazarika, P.; Zhang, C.; Talpur, R. and Duvic, M. (2001): Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?, Clin Cancer Res 7 [9], pp.2682-92. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11555580 Nielsen, M. B.; Kirkin, A. F.; Loftus, D.; Nissen, M. H.; Rivoltini, L.; Zeuthen, J.; Geisler, C. and Odum, N. (2000): Amino acid substitutions in the melanoma antigen recognized by T cell 1 peptide modulate cytokine responses in melanoma-specific T cells, J Immunother 23 [4], pp.405-11. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10916749 Nikolova, M.; Bagot, M.; Boumsell, L. and Bensussan, A. (2002): Identification of cell surface molecules characterizing human cutaneous T-cell lymphomas, Leuk Lymphoma 43 [4], pp.741-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12153159 Nocentini, G.; Giunchi, L.; Ronchetti, S.; Krausz, L. T.; Bartoli, A.; Moraca, R.; Migliorati, G. and Riccardi, C. (1997): A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis, Proc Natl Acad Sci U S A 94 [12], pp.6216-21. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9177197 Novellino, L.; Renkvist, N.; Rini, F.; Mazzocchi, A.; Rivoltini, L.; Greco, A.; Deho, P.; Squarcina, P.; Robbins, P. F.; Parmiani, G. and Castelli, C. (2003): Identification of a mutated receptor-like protein tyrosine phosphatase kappa as a novel, class II HLA-restricted melanoma antigen, J Immunol 170 [12], pp.6363-70. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12794170 Oxenius, A.; Bachmann, M. F.; Ashton-Rickardt, P. G.; Tonegawa, S.; Zinkernagel, R. M. and Hengartner, H. (1995): Presentation of endogenous viral proteins in association with major histocompatibility complex class II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system, Eur J Immunol 25 [12], pp.3402-11. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8566030 Parham, P. (2000): NK cell receptors: of missing sugar and missing self, Curr Biol 10 [5], pp.R195-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10712900 Pasternack, M. S.; Verret, C. R.; Liu, M. A. and Eisen, H. N. (1986): Serine esterase in cytolytic T lymphocytes, Nature 322 [6081], pp.740-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3489187 Pfreundschuh, M.; Shiku, H.; Takahashi, T.; Ueda, R.; Ransohoff, J.; Oettgen, H. F. and Old, L. J. (1978): Serological analysis of cell surface antigens of malignant human brain tumors, Proc Natl Acad Sci U S A 75 [10], pp.5122-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=283420 Pinet, V. M. and Long, E. O. (1998): Peptide loading onto recycling HLA-DR molecules occurs in early endosomes, Eur J Immunol 28 [3], pp.799-804. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9541573 Pinet, V.; Malnati, M. S. and Long, E. O. (1994): Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen, J Immunol 152 [10], pp.4852-60. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8176208 Pinilla, C.; Rubio-Godoy, V.; Dutoit, V.; Guillaume, P.; Simon, R.; Zhao, Y.; Houghten, R. A.; Cerottini, J. C.; Romero, P. and Valmori, D. (2001): Combinatorial peptide libraries as an alternative approach to the identification of ligands for tumor-reactive cytolytic T lymphocytes, Cancer Res 61 [13], pp.5153-60. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11431354 Podack ER, Konigsberg PJ. (1984): Cytolytic T cell granules. Isolation, structural, biochemical, and functional characterization., J Exp Med. 1984 Sep 1;160(3):695-710.. Polverini, P. J. (1996): Cellular adhesion molecules. Newly identified mediators of angiogenesis, Am J Pathol 148 [4], pp.1023-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8644843 Powell, D. J., Jr. and Rosenberg, S. A. (2004): Phenotypic and functional maturation of tumor antigen-reactive CD8+ T lymphocytes in patients undergoing multiple course peptide vaccination, J Immunother 27 [1], pp.36-47. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14676632 Rammensee, H. G.; Friede, T. and Stevanoviic, S. (1995): MHC ligands and peptide motifs: first listing, Immunogenetics 41 [4], pp.178-228. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7890324 Rappl, G.; Muche, J. M.; Abken, H.; Sterry, W.; Tilgen, W.; Ugurel, S. and Reinhold, U. (2001): CD4(+)CD7(-) T cells compose the dominant T-cell clone in the peripheral blood of patients with Sezary syndrome, J Am Acad Dermatol 44 [3], pp.456-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11209115 Rees, W.; Bender, J.; Teague, T. K.; Kedl, R. M.; Crawford, F.; Marrack, P. and Kappler, J. (1999): An inverse relationship between T cell receptor affinity and antigen dose during CD4(+) T cell responses in vivo and in vitro, Proc Natl Acad Sci U S A 96 [17], pp.9781-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10449771 Rezvani, K.; Grube, M.; Brenchley, J. M.; Sconocchia, G.; Fujiwara, H.; Price, D. A.; Gostick, E.; Yamada, K.; Melenhorst, J.; Childs, R.; Hensel, N.; Douek, D. C. and Barrett, A. J. (2003): Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation, Blood 102 [8], pp.2892-900. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12829610 Rich, S.; Seelig, M.; Lee, H. M. and Lin, J. (1995): Transforming growth factor beta 1 costimulated growth and regulatory function of staphylococcal enterotoxin B-responsive CD8+ T cells, J Immunol 155 [2], pp.609-18. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7608539 Rivoltini, L.; Squarcina, P.; Loftus, D. J.; Castelli, C.; Tarsini, P.; Mazzocchi, A.; Rini, F.; Viggiano, V.; Belli, F. and Parmiani, G. (1999): A superagonist variant of peptide MART1/Melan A27-35 elicits anti-melanoma CD8+ T cells with enhanced functional characteristics: implication for more effective immunotherapy, Cancer Res 59 [2], pp.301-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9927036 Robbins, P. F.; El-Gamil, M.; Li, Y. F.; Fitzgerald, E. B.; Kawakami, Y. and Rosenberg, S. A. (1997): The intronic region of an incompletely spliced gp100 gene transcript encodes an epitope recognized by melanoma-reactive tumor-infiltrating lymphocytes, J Immunol 159 [1], pp.303-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9200467 Roberts, A. B. (2002): The ever-increasing complexity of TGF-beta signaling, Cytokine Growth Factor Rev 13 [1], pp.3-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11750874 Rocha, B.; Vassalli, P. and Guy-Grand, D. (1994): Thymic and extrathymic origins of gut intraepithelial lymphocyte populations in mice, J Exp Med 180 [2], pp.681-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8046341 Roncarolo, M. G. and Levings, M. K. (2000): The role of different subsets of T regulatory cells in controlling autoimmunity, Curr Opin Immunol 12 [6], pp.676-83. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11102772 Ronsin, C.; Chung-Scott, V.; Poullion, I.; Aknouche, N.; Gaudin, C. and Triebel, F. (1999): A non-AUG-defined alternative open reading frame of the intestinal carboxyl esterase mRNA generates an epitope recognized by renal cell carcinoma-reactive tumor-infiltrating lymphocytes in situ, J Immunol 163 [1], pp.483-90. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10384152 Rouvier, E.; Luciani, M. F. and Golstein, P. (1993): Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity, J Exp Med 177 [1], pp.195-200. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7678113 Rubio-Godoy, V.; Ayyoub, M.; Dutoit, V.; Servis, C.; Schink, A.; Rimoldi, D.; Romero, P.; Cerottini, J. C.; Simon, R.; Zhao, Y.; Houghten, R. A.; Pinilla, C. and Valmori, D. (2002): Combinatorial peptide library-based identification of peptide ligands for tumor-reactive cytolytic T lymphocytes of unknown specificity, Eur J Immunol 32 [8], pp.2292-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12209642 Rubio-Godoy, V.; Dutoit, V.; Rimoldi, D.; Lienard, D.; Lejeune, F.; Speiser, D.; Guillaume, P.; Cerottini, J. C.; Romero, P. and Valmori, D. (2001): Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life, Proc Natl Acad Sci U S A 98 [18], pp.10302-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11517329 Rubio-Godoy, V.; Dutoit, V.; Zhao, Y.; Simon, R.; Guillaume, P.; Houghten, R.; Romero, P.; Cerottini, J. C.; Pinilla, C. and Valmori, D. (2002): Positional scanning-synthetic peptide library-based analysis of self- and pathogen-derived peptide cross-reactivity with tumor-reactive Melan-A-specific CTL, J Immunol 169 [10], pp.5696-707. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12421949 Rudensky, AYu; Preston-Hurlburt, P.; Hong, S. C.; Barlow, A. and Janeway, C. A., Jr. (1991): Sequence analysis of peptides bound to MHC class II molecules, Nature 353 [6345], pp.622-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1656276 Sahin, U.; Tureci, O.; Schmitt, H.; Cochlovius, B.; Johannes, T.; Schmits, R.; Stenner, F.; Luo, G.; Schobert, I. and Pfreundschuh, M. (1995): Human neoplasms elicit multiple specific immune responses in the autologous host, Proc Natl Acad Sci U S A 92 [25], pp.11810-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8524854 Sakaguchi, S.; Sakaguchi, N.; Shimizu, J.; Yamazaki, S.; Sakihama, T.; Itoh, M.; Kuniyasu, Y.; Nomura, T.; Toda, M. and Takahashi, T. (2001): Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance, Immunol Rev 182, pp.18-32. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11722621 Salazar, E.; Zaremba, S.; Arlen, P. M.; Tsang, K. Y. and Schlom, J. (2000): Agonist peptide from a cytotoxic t-lymphocyte epitope of human carcinoembryonic antigen stimulates production of tc1-type cytokines and increases tyrosine phosphorylation more efficiently than cognate peptide, Int J Cancer 85 [6], pp.829-38. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10709104 Sallusto, F.; Lenig, D.; Forster, R.; Lipp, M. and Lanzavecchia, A. (1999): Two subsets of memory T lymphocytes with distinct homing potentials and effector functions, Nature 401 [6754], pp.708-12. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10537110 Sato, N.; Kokame, K.; Shimokado, K.; Kato, H. and Miyata, T. (1998): Changes of gene expression by lysophosphatidylcholine in vascular endothelial cells: 12 up-regulated distinct genes including 5 cell growth-related, 3 thrombosis-related, and 4 others, J Biochem (Tokyo) 123 [6], pp.1119-26. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9604001 Savage, P. A.; Boniface, J. J. and Davis, M. M. (1999): A kinetic basis for T cell receptor repertoire selection during an immune response, Immunity 10 [4], pp.485-92. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10229191 Schwartz, R. H. (1985): T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex, Annu Rev Immunol 3, pp.237-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2415139 Seifert, U.; Maranon, C.; Shmueli, A.; Desoutter, J. F.; Wesoloski, L.; Janek, K.; Henklein, P.; Diescher, S.; Andrieu, M.; de la Salle, H.; Weinschenk, T.; Schild, H.; Laderach, D.; Galy, A.; Haas, G.; Kloetzel, P. M.; Reiss, Y. and Hosmalin, A. (2003): An essential role for tripeptidyl peptidase in the generation of an MHC class I epitope, Nat Immunol 4 [4], pp.375-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12598896 Sell, S.; Becker, F. F.; Leffert, H. L. and Watabe, L. (1976): Expression of an oncodevelopmental gene product (alpha-fetoprotein) during fetal development and adult oncogenesis, Cancer Res 36 [11 Pt. 2], pp.4239-49. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=61804 Seo, N.; Tokura, Y.; Matsumoto, K.; Furukawa, F. and Takigawa, M. (1998): Tumour-specific cytotoxic T lymphocyte activity in Th2-type Sezary syndrome: its enhancement by interferon-gamma (IFN-gamma) and IL-12 and fluctuations in association with disease activity, Clin Exp Immunol 112 [3], pp.403-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9649208 Shevach, E. M.; McHugh, R. S.; Thornton, A. M.; Piccirillo, C.; Natarajan, K. and Margulies, D. H. (2001): Control of autoimmunity by regulatory T cells, Adv Exp Med Biol 490, pp.21-32. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11505971 Shimizu, J.; Yamazaki, S.; Takahashi, T.; Ishida, Y. and Sakaguchi, S. (2002): Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance, Nat Immunol 3 [2], pp.135-42. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11812990 Shimono, A.; Okuda, T. and Kondoh, H. (1999): N-myc-dependent repression of ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant, Mech Dev 83 [1-2], pp.39-52. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10381566 Slifka, M. K. and Whitton, J. L. (2001): Functional avidity maturation of CD8(+) T cells without selection of higher affinity TCR, Nat Immunol 2 [8], pp.711-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11477407 Sloan, V. S.; Cameron, P.; Porter, G.; Gammon, M.; Amaya, M.; Mellins, E. and Zaller, D. M. (1995): Mediation by HLA-DM of dissociation of peptides from HLA-DR, Nature 375 [6534], pp.802-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7596415 Speir, J. A.; Garcia, K. C.; Brunmark, A.; Degano, M.; Peterson, P. A.; Teyton, L. and Wilson, I. A. (1998): Structural basis of 2C TCR allorecognition of H-2Ld peptide complexes, Immunity 8 [5], pp.553-62. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9620676 Steiner, M. S.; Zhou, Z. Z.; Tonb, D. C. and Barrack, E. R. (1994): Expression of transforming growth factor-beta 1 in prostate cancer, Endocrinology 135 [5], pp.2240-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7956947 Stern, L. J.; Brown, J. H.; Jardetzky, T. S.; Gorga, J. C.; Urban, R. G.; Strominger, J. L. and Wiley, D. C. (1994): Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide, Nature 368 [6468], pp.215-21. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8145819 Sterry, W. and Mielke, V. (1989): CD4+ cutaneous T-cell lymphomas show the phenotype of helper/inducer T cells (CD45RA-, CDw29+), J Invest Dermatol 93 [3], pp.413-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2527911 Tepper, A. D.; Cock, J. G.; de Vries, E.; Borst, J. and van Blitterswijk, W. J. (1997): CD95/Fas-induced ceramide formation proceeds with slow kinetics and is not blocked by caspase-3/CPP32 inhibition, J Biol Chem 272 [39], pp.24308-12. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9305886 Thangavelu, M.; Finn, W. G.; Yelavarthi, K. K.; Roenigk, H. H., Jr.; Samuelson, E.; Peterson, L.; Kuzel, T. M. and Rosen, S. T. (1997): Recurring structural chromosome abnormalities in peripheral blood lymphocytes of patients with mycosis fungoides/Sezary syndrome, Blood 89 [9], pp.3371-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9129044 Tourdot, S.; Scardino, A.; Saloustrou, E.; Gross, D. A.; Pascolo, S.; Cordopatis, P.; Lemonnier, F. A. and Kosmatopoulos, K. (2000): A general strategy to enhance immunogenicity of low-affinity HLA-A2. 1-associated peptides: implication in the identification of cryptic tumor epitopes, Eur J Immunol 30 [12], pp.3411-21. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11093159 Townsend, A.; Bastin, J.; Gould, K.; Brownlee, G.; Andrew, M.; Coupar, B.; Boyle, D.; Chan, S. and Smith, G. (1988): Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen, J Exp Med 168 [4], pp.1211-24. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2459295 Trefzer, U.; Herberth, G.; Wohlan, K.; Milling, A.; Thiemann, M.; Sherev, T.; Sparbier, K.; Sterry, W. and Walden, P. (2004): Vaccination with hybrids of tumor and dendritic cells induces tumor-specific T-cell and clinical responses in melanoma stage III and IV patients, Int J Cancer 110 [5], pp.730-40. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15146563 Tsamandas, A. C.; Kardamakis, D.; Ravazoula, P.; Zolota, V.; Salakou, S.; Tepetes, K.; Kalogeropoulou, C.; Tsota, I.; Kourelis, T.; Makatsoris, T.; Karavias, D.; Scopa, C. D.; Bonikos, D. S.; Kalofonos, H. P. and Petsas, T. (2004): The potential role of TGFbeta1, TGFbeta2 and TGFbeta3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival, Strahlenther Onkol 180 [4], pp.201-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15057430 Tschopp, J. and Jongeneel, C. V. (1988): Cytotoxic T lymphocyte mediated cytolysis, Biochemistry 27 [8], pp.2641-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3042021 Tumenjargal, S.; Gellrich, S.; Linnemann, T.; Muche, J. M.; Lukowsky, A.; Audring, H.; Wiesmuller, K. H.; Sterry, W. and Walden, P. (2003): Anti-tumor immune responses and tumor regression induced with mimotopes of a tumor-associated T cell epitope, Eur J Immunol 33 [11], pp.3175-85. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14579286 Udaka, K.; Wiesmuller, K. H.; Kienle, S.; Jung, G. and Walden, P. (1995): Decrypting the structure of major histocompatibility complex class I-restricted cytotoxic T lymphocyte epitopes with complex peptide libraries, J Exp Med 181 [6], pp.2097-108. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7539039 Udaka, K.; Wiesmuller, K. H.; Kienle, S.; Jung, G. and Walden, P. (1996): Self-MHC-restricted peptides recognized by an alloreactive T lymphocyte clone, J Immunol 157 [2], pp.670-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8752916 Valitutti, S. and Lanzavecchia, A. (1997): Serial triggering of TCRs: a basis for the sensitivity and specificity of antigen recognition, Immunol Today 18 [6], pp.299-304. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9190117 Valmori, D.; Dutoit, V.; Schnuriger, V.; Quiquerez, A. L.; Pittet, M. J.; Guillaume, P.; Rubio-Godoy, V.; Walker, P. R.; Rimoldi, D.; Lienard, D.; Cerottini, J. C.; Romero, P. and Dietrich, P. Y. (2002): Vaccination with a Melan-A peptide selects an oligoclonal T cell population with increased functional avidity and tumor reactivity, J Immunol 168 [8], pp.4231-40. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11937585 Valmori, D.; Fonteneau, J. F.; Lizana, C. M.; Gervois, N.; Lienard, D.; Rimoldi, D.; Jongeneel, V.; Jotereau, F.; Cerottini, J. C. and Romero, P. (1998): Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues, J Immunol 160 [4], pp.1750-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9469433 Valmori, D.; Gervois, N.; Rimoldi, D.; Fonteneau, J. F.; Bonelo, A.; Lienard, D.; Rivoltini, L.; Jotereau, F.; Cerottini, J. C. and Romero, P. (1998): Diversity of the fine specificity displayed by HLA-A*0201-restricted CTL specific for the immunodominant Melan-A/MART-1 antigenic peptide, J Immunol 161 [12], pp.6956-62. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9862730 van Belzen, N.; Dinjens, W. N.; Diesveld, M. P.; Groen, N. A.; van der Made, A. C.; Nozawa, Y.; Vlietstra, R.; Trapman, J. and Bosman, F. T. (1997): A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms, Lab Invest 77 [1], pp.85-92. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9251681 van der Bruggen, P.; Traversari, C.; Chomez, P.; Lurquin, C.; De Plaen, E.; Van den Eynde, B.; Knuth, A. and Boon, T. (1991): A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma, Science 254 [5038], pp.1643-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1840703 Varshavsky, A. (1997): The ubiquitin system, Trends Biochem Sci 22 [10], pp.383-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9357313 Vassilakos, A.; Cohen-Doyle, M. F.; Peterson, P. A.; Jackson, M. R. and Williams, D. B. (1996): The molecular chaperone calnexin facilitates folding and assembly of class I histocompatibility molecules, Embo J 15 [7], pp.1495-506. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8612572 Verheij, M.; Bose, R.; Lin, X. H.; Yao, B.; Jarvis, W. D.; Grant, S.; Birrer, M. J.; Szabo, E.; Zon, L. I.; Kyriakis, J. M.; Haimovitz-Friedman, A.; Fuks, Z. and Kolesnick, R. N. (1996): Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis, Nature 380 [6569], pp.75-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8598911 Walunas, T. L.; Lenschow, D. J.; Bakker, C. Y.; Linsley, P. S.; Freeman, G. J.; Green, J. M.; Thompson, C. B. and Bluestone, J. A. (1994): CTLA-4 can function as a negative regulator of T cell activation, Immunity 1 [5], pp.405-13. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7882171 Wang, H. Y.; Lee, D. A.; Peng, G.; Guo, Z.; Li, Y.; Kiniwa, Y.; Shevach, E. M. and Wang, R. F. (2004): Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy, Immunity 20 [1], pp.107-18. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14738769 Wang-Johanning, F.; Frost, A. R.; Jian, B.; Epp, L.; Lu, D. W. and Johanning, G. L. (2003): Quantitation of HERV-K env gene expression and splicing in human breast cancer, Oncogene 22 [10], pp.1528-35. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12629516 Whiteside, T. L. and Rabinowich, H. (1998): The role of Fas/FasL in immunosuppression induced by human tumors, Cancer Immunol Immunother 46 [4], pp.175-84. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9671140 Willemze, R.; Kerl, H.; Sterry, W.; Berti, E.; Cerroni, L.; Chimenti, S.; Diaz-Perez, J. L.; Geerts, M. L.; Goos, M.; Knobler, R.; Ralfkiaer, E.; Santucci, M.; Smith, N.; Wechsler, J.; van Vloten, W. A. and Meijer, C. J. (1997): EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer, Blood 90 [1], pp.354-71. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9207472 Winter, D.; Fiebiger, E.; Meraner, P.; Auer, H.; Brna, C.; Strohal, R.; Trautinger, F.; Knobler, R.; Fischer, G. F.; Stingl, G. and Maurer, D. (2003): Definition of TCR epitopes for CTL-mediated attack of cutaneous T cell lymphoma, J Immunol 171 [5], pp.2714-24. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12928425 Wolf, P. R. and Ploegh, H. L. (1995): How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway, Annu Rev Cell Dev Biol 11, pp.267-306. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8689559 Woll, M. M.; Fisher, C. M.; Ryan, G. B.; Gurney, J. M.; Storrer, C. E.; Ioannides, C. G.; Shriver, C. D.; Moul, J. W.; McLeod, D. G.; Ponniah, S. and Peoples, G. E. (2004): Direct Measurement of Peptide-specific Cd8+ T Cells Using Hla-a2:ig Dimer for Monitoring the in Vivo Immune Response to a Her2/neu Vaccine in Breast and Prostate Cancer Patients, J Clin Immunol 24 [4], pp.449-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15163902 Woo, E. Y.; Yeh, H.; Chu, C. S.; Schlienger, K.; Carroll, R. G.; Riley, J. L.; Kaiser, L. R. and June, C. H. (2002): Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation, J Immunol 168 [9], pp.4272-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11970966 Yee, C.; Savage, P. A.; Lee, P. P.; Davis, M. M. and Greenberg, P. D. (1999): Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers, J Immunol 162 [4], pp.2227-34. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9973498 Yu, J.; Zhang, L.; Hwang, P. M.; Rago, C.; Kinzler, K. W. and Vogelstein, B. (1999): Identification and classification of p53-regulated genes, Proc Natl Acad Sci U S A 96 [25], pp.14517-22. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10588737 Zheng, S. G.; Wang, J. H.; Koss, M. N.; Quismorio, F., Jr.; Gray, J. D. and Horwitz, D. A. (2004): CD4+ and CD8+ regulatory T cells generated ex vivo with IL-2 and TGF-beta suppress a stimulatory graft-versus-host disease with a lupus-like syndrome, J Immunol 172 [3], pp.1531-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14734731 Zhou, D.; Salnikow, K. and Costa, M. (1998): Cap43, a novel gene specifically induced by Ni2+ compounds, Cancer Res 58 [10], pp.2182-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9605764 Zoi-Toli, O.; Vermeer, M. H.; De Vries, E.; Van Beek, P.; Meijer, C. J. and Willemze, R. (2000): Expression of Fas and Fas-ligand in primary cutaneous T-cell lymphoma (CTCL): association between lack of Fas expression and aggressive types of CTCL, Br J Dermatol 143 [2], pp.313-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10951138